Mysona DP - Search Results

1

High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.

Brzezinska B, Mysona DP, Richardson KP, Rungruang B, Hopkins D, Bearden G, Higgins R, Johnson M, Satter KB, McIndoe R, Ghamande S, Purohit S. Brzezinska B, et al. Among authors: mysona dp. Gynecol Oncol. 2023 Dec;179:1-8. doi: 10.1016/j.ygyno.2023.10.009. Epub 2023 Oct 19. Gynecol Oncol. 2023. PMID: 37862814

2

Multiplex glycan bead array for high throughput and high content analyses of glycan binding proteins.

Purohit S, Li T, Guan W, Song X, Song J, Tian Y, Li L, Sharma A, Dun B, Mysona D, Ghamande S, Rungruang B, Cummings RD, Wang PG, She JX. Purohit S, et al. Nat Commun. 2018 Jan 17;9(1):258. doi: 10.1038/s41467-017-02747-y. Nat Commun. 2018. PMID: 29343722 Free PMC article.

3

A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer.

Mysona D, Pyrzak A, Purohit S, Zhi W, Sharma A, Tran L, Tran P, Bai S, Rungruang B, Ghamande S, She JX. Mysona D, et al. Gynecol Oncol. 2019 Mar;152(3):574-580. doi: 10.1016/j.ygyno.2018.12.015. Epub 2018 Dec 18. Gynecol Oncol. 2019. PMID: 30578005 Free PMC article.

4

Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers.

Mysona DP, Tran LKH, Tran PMH, Gehrig PA, Van Le L, Ghamande S, Rungruang BJ, Java J, Mann AK, Liao J, Kapp DS, Santos BD, She JX, Chan JK. Mysona DP, et al. Gynecol Oncol. 2020 Jan;156(1):77-84. doi: 10.1016/j.ygyno.2019.10.017. Epub 2019 Nov 30. Gynecol Oncol. 2020. PMID: 31796203

5

Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.

Vaz J, Tian C, Richardson MT, Chan JK, Mysona D, Rao UN, Powell MA, Shriver CD, Hamilton CA, Casablanca Y, Maxwell GL, Darcy KM. Vaz J, et al. Gynecol Oncol. 2020 Apr;157(1):121-130. doi: 10.1016/j.ygyno.2019.12.008. Epub 2020 Jan 15. Gynecol Oncol. 2020. PMID: 31954536

6

Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy.

Purohit S, Ferris DG, Alvarez M, Tran PMH, Tran LKH, Mysona DP, Hopkins D, Zhi W, Dun B, Wallbillich JJ, Cummings RD, Wang PG, She JX. Purohit S, et al. Among authors: mysona dp. Gynecol Oncol. 2020 Apr;157(1):181-187. doi: 10.1016/j.ygyno.2020.01.014. Epub 2020 Jan 17. Gynecol Oncol. 2020. PMID: 31955861 Free PMC article.

7

A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy.

Tran LKH, Tran PMH, Mysona DP, Purohit SB, Myers E, Lee WS, Dun B, Xu D, Liu H, Hopkins D, Nechtman J, Scelsi CL, Mittal PK, Kleven D, Wallbillich JJ, Rungruang B, Ghamande S, She JX. Tran LKH, et al. Among authors: mysona dp. Gynecol Oncol. 2020 May;157(2):340-347. doi: 10.1016/j.ygyno.2020.02.015. Epub 2020 Feb 14. Gynecol Oncol. 2020. PMID: 32067813

8

Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit.

Richardson MT, Mysona DP, Klein DA, Mann A, Liao CI, Diver EJ, Darcy KM, Tian C, She JX, Ghamande S, Van Le L, Kapp DS, Chan JK. Richardson MT, et al. Among authors: mysona dp. Gynecol Oncol. 2020 Oct;159(1):118-128. doi: 10.1016/j.ygyno.2020.07.011. Epub 2020 Aug 20. Gynecol Oncol. 2020. PMID: 32828578

9

Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?

Mysona DP, Ghamande S, She JX, Tran L, Tran P, Rungruang BJ, Chan JK, Bae-Jump V, Gehrig PA. Mysona DP, et al. Ann Surg Oncol. 2021 Jul;28(7):3605-3615. doi: 10.1245/s10434-020-09304-w. Epub 2020 Nov 5. Ann Surg Oncol. 2021. PMID: 33155151

10

Tumor-intrinsic and -extrinsic (immune) gene signatures robustly predict overall survival and treatment response in high grade serous ovarian cancer patients.

Mysona DP, Tran L, Bai S, Dos Santos B, Ghamande S, Chan J, She JX. Mysona DP, et al. Am J Cancer Res. 2021 Jan 1;11(1):181-199. eCollection 2021. Am J Cancer Res. 2021. PMID: 33520368 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters